Pamela P. Palmer
2020
In 2020, Pamela P. Palmer earned a total compensation of $962.1K as Chief Medical Officer at AcelRx Pharmaceuticals, a 11% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,125 |
|---|---|
| Option Awards | $168,111 |
| Salary | $496,236 |
| Stock Awards | $118,250 |
| Other | $11,400 |
| Total | $962,122 |
Palmer received $496.2K in salary, accounting for 52% of the total pay in 2020.
Palmer also received $168.1K in non-equity incentive plan, $168.1K in option awards, $118.3K in stock awards and $11.4K in other compensation.
Rankings
In 2020, Pamela P. Palmer's compensation ranked 8,795th out of 13,090 executives tracked by ExecPay. In other words, Palmer earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,795 out of 13,090 | 33rd |
Division Manufacturing | 3,748 out of 5,621 | 33rd |
Major group Chemicals And Allied Products | 1,514 out of 2,254 | 33rd |
Industry group Drugs | 1,319 out of 1,954 | 33rd |
Industry Pharmaceutical Preparations | 975 out of 1,459 | 33rd |
Source: SEC filing on June 3, 2022.
Palmer's colleagues
We found two more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2020.
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019